Novozymes Statistics

Total Valuation

Novozymes has a market cap or net worth of DKK 217.44 billion. The enterprise value is 230.34 billion.

Market Cap	217.44B
Enterprise Value	230.34B

Important Dates

The last earnings date was Wednesday, August 28, 2024.

Earnings Date	Aug 28, 2024
Ex-Dividend Date	Aug 30, 2024

Share Statistics

Novozymes has 464.62 million shares outstanding. The number of shares has decreased by -0.26% in one year.

Shares Outstanding	464.62M
Shares Change (YoY)	-0.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	27.11%
Float	345.19M

Valuation Ratios

The trailing PE ratio is 61.53 and the forward PE ratio is 35.27. Novozymes's PEG ratio is 3.81.

PE Ratio	61.53
Forward PE	35.27
PS Ratio	5.70
PB Ratio	1.58
P/FCF Ratio	46.17
PEG Ratio	3.81

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.51, with an EV/FCF ratio of 48.91.

EV / Earnings	109.22
EV / Sales	10.14
EV / EBITDA	39.51
EV / EBIT	59.22
EV / FCF	48.91

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 18.08.

Current Ratio	1.11
Quick Ratio	0.67
Debt / Equity	18.08
Debt / EBITDA	2.53
Debt / FCF	3.15
Interest Coverage	11.54

Financial Efficiency

Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.

Return on Equity (ROE)	4.38%
Return on Assets (ROA)	3.45%
Return on Capital (ROIC)	4.12%
Revenue Per Employee	2.17M
Profits Per Employee	201,775
Employee Count	6,756
Asset Turnover	0.32
Inventory Turnover	2.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +55.95% in the last 52 weeks. The beta is 0.52, so Novozymes's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	+55.95%
50-Day Moving Average	433.28
200-Day Moving Average	397.00
Relative Strength Index (RSI)	77.66
Average Volume (20 Days)	549,190

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novozymes had revenue of DKK 22.71 billion and earned 2.11 billion in profits. Earnings per share was 7.61.

Revenue	22.71B
Gross Profit	10.60B
Operating Income	3.92B
Pretax Income	2.74B
Net Income	2.11B
EBITDA	4.98B
EBIT	3.92B
Earnings Per Share (EPS)	7.61

Full Income Statement

Balance Sheet

The company has 1.94 billion in cash and 14.83 billion in debt, giving a net cash position of -12.89 billion or -27.74 per share.

Cash & Cash Equivalents	1.94B
Total Debt	14.83B
Net Cash	-12.89B
Net Cash Per Share	-27.74
Equity (Book Value)	82.07B
Book Value Per Share	295.29
Working Capital	1.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.64 billion and capital expenditures -1.93 billion, giving a free cash flow of 4.71 billion.

Operating Cash Flow	6.64B
Capital Expenditures	-1.93B
Free Cash Flow	4.71B
FCF Per Share	10.14

Full Cash Flow Statement

Margins

Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.

Gross Margin	46.66%
Operating Margin	17.24%
Pretax Margin	12.07%
Profit Margin	9.29%
EBITDA Margin	21.92%
EBIT Margin	17.24%
FCF Margin	20.74%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.86%.

Dividend Per Share	4.00
Dividend Yield	0.86%
Dividend Growth (YoY)	-60.78%
Years of Dividend Growth	2
Payout Ratio	99.19%
Buyback Yield	0.26%
Shareholder Yield	1.11%
Earnings Yield	1.63%
FCF Yield	2.17%

Dividend Details

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5